Kathleen A. Havlin - Concepedia

Author

Kathleen A. Havlin

The University of Texas Health Science Center at San Antonio

Also Known As

K A Havlin, K Havlin, K. A. Havlin, K. Havlin, KATHLEEN A. HAVLIN, Kathleen A Havlin, Kathleen A. Havlin, Kathleen Anne Havlin, Kathleen Havlin

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Duke Medical Center NorthShore University HealthSystem

About

Kathleen A. Havlin is an author at The University of Texas Health Science Center at San Antonio specializing in oncology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	507
2	Health Sciences	3	3	263
3	Social Sciences	1	1	17
4	Cognitive Science	1	1	17
5	Obstetrics	1	1	18

Kathleen A. Havlin

Publications

902

Citations

H-Index

Page 1

	Year	Citations
Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom, Journal of Clinical Oncology	2003	345
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy Wendy Demark‐Wahnefried, Vera Hárs, MR Conaway, American Journal of Clinical Nutrition Physical ActivityOncologyBreast OncologyBreast Cancer PatientsExercise	1997	207
A phase I trial of taxol given by a 6-hour intravenous infusion. T.D. Brown, Kathleen A. Havlin, Geoffrey R. Weiss, Journal of Clinical Oncology Pharmaceutical ScienceOncologyPhase Ii InvestigationPharmacologyClinical Trials	1991	182
Phase I clinical investigation of amonafide. Ruben A. Saez, John B. Craig, John G. Kuhn, Journal of Clinical Oncology Hematological MalignancyAmonafide PlasmaOncologyDrug InfusionMedicine	1989	43
High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study Kathleen A. Havlin, John G. Kuhn, Judith Myers, Cancer	1989	22
Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer Veerpal Singh, Ishfaq Bhat, Kathleen A. Havlin Journal of Neuro-Oncology MedicinePathologyGynecologyMarantic EndocarditisOncology	2007	18
A phase II study of piritrexim in patients with advanced squamous head and neck cancer Wu‐Ching Uen, Andrew T. Huang, Robert Mennel, Cancer Neck CancerChemoprevention StrategyPathologyPhase Ii StudyPharmacotherapy	1992	17
Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis Lynne I. Wagner, Jerry J. Sweet, Zeeshan Butt, Journal of Clinical Oncology NeuropsychologyCancer ManagementEpidemiology Of CancerCancer PatientsCognitive Rehabilitation	2006	17
Etoposide in gastric cancer. J. S. Macdonald, Kathleen A. Havlin PubMed	1992	15
Induced Proteins in Human Peripheral Mononuclear Cells Over a Range of Clinically Tolerable Doses of Interferon-γ Donna M. Paulnock, Kathleen A. Havlin, BARRY M. STORER, Journal of Interferon Research	1989	13

Page 1